Related Experiment Videos
Small cell carcinoma of the prostate
P G Hagood1, F E Johnson, C W Bedrossian
1Department of Surgery, St. Louis University Medical Center, Missouri 63110-0250.
Cancer
|February 15, 1991
Summary
This study examines a prostate cancer patient with high glucagon levels and neuroendocrine markers. Findings suggest neuroendocrine activity is common in small cell carcinomas, irrespective of origin.
Area of Science:
- Oncology
- Endocrinology
- Pathology
Background:
- Small cell undifferentiated carcinoma of the prostate is a rare and aggressive malignancy.
- Systemic hyperglucagonemia can occur in association with certain cancers.
- Ectopic hormone production is a known phenomenon in neuroendocrine tumors.
Observation:
- A case study of a patient with small cell undifferentiated carcinoma of the prostate and systemic hyperglucagonemia.
- Evaluation of serologic markers to detect ectopic hormonal production.
- Immunocytochemical analysis of primary prostate tumor and lung metastasis.
Findings:
- Prostate and lung tumor tissues stained positive for corticotropin (ACTH) and gastrin.
- No definitive evidence of excess hormone secretion was documented.
- Neuroendocrine markers were identified in both primary and metastatic sites.
Implications:
- The findings support the hypothesis that neuroendocrine activity is a common feature of undifferentiated small cell carcinomas.
- This supports the understanding of the pathophysiology of small cell prostate cancer.
- Further research into the role of neuroendocrine markers in prostate cancer prognosis and treatment is warranted.